Authors
Latest:
Osteoarthritis Management: Determine What Patients Know, Then Fill in GapsIn patients already using analgesics for pain control, pharmacists need to address medication adherence for improved osteoarthritis symptom control.
Latest:
Let’s Not Forget the Silent Killer: HypertensionThe prevalence of hypertension continues to increase amongst adults in the United States, leading to other cardiovascular conditions. Lifestyle changes and medication adherence are essential for appropriate hypertension management.
Latest:
Are OTC Proton Pump Inhibitors a Boon Or a Curse?The risk of therapy duplication with OTC and prescription PPIs can be lowered with an innovative, multi-faceted, and intentional approach by pharmacy teams and prescribers.
Latest:
Multisite Health-Systems Specialty Pharmacy Study Evaluates Adherence to Self-Administered Biologic Disease-Modifying Antirheumatic DrugsHigh adherence to treatment is a key first step toward better patient outcomes, including sustained disease control or remission.
Latest:
Three Strategies for Pharmacists to Maximize Their Potential as Caregivers Beyond the BenchIn recent years, pharmacist roles have evolved as critically important caregivers who increasingly provide essential health care services far beyond medication dispensing.
Latest:
Common Patient Questions About Insulin Biosimilars Pertain to ClassificationNuances can lead to frequent areas of confusion.
Latest:
AAN 2025: AI's Promising Role in Cognitive Decline Research and Personalized MedicineStephanie Miller, PhD discusses how artificial intelligence can revolutionize medical research by assisting in drug development and potentially providing more targeted treatments across various diseases.
Latest:
Evaluation of a Chemotherapy Advanced Preparation Pilot Program to Improve Throughput in an Oncology Infusion ClinicPharmacy workflow changes in the preparation of chemotherapy products can reduce patient chair time.
Latest:
There Are Two Significant Advantages to the Decriminalization of PsychedelicsTo build a brighter, healthier, and more equitable future for all US citizens, there is an indisputable need to decriminalize psychedelic medicines.
Latest:
Advancing Treatment Selection in CLL ManagementTreatment options are distinct in their mechanisms, safety profiles, and implications for patients’ quality of life.
Latest:
Telehealth & AI: Enhancing Accessibility and Continuity in Patient CareThe transformation brought about by these technologies is akin to a revolution in health care.
Latest:
FDA Sheds Light on New Drug Approvals in Breast CancerThe FDA is modernizing its approach to drug development and optimization.
Latest:
Advise Patients to Use Caution When Purchasing Nootropic Agents OnlineAlthough each of the product samples of phenibut contained the actual active ingredient, the exact amount of the active ingredient was inaccurate and, in one sample, found to be at a higher dose.
Latest:
Illegal Online Pharmacies Are Putting Patients at RiskThe growing volume of drugs sold through illegal online pharmacies are estimated to generate 10 times higher adverse event rates than drugs sold through legal pharmacies.
Latest:
Navigating the Great Medicare Migration: How Pharmacists Can Build Stronger Patient Relationships During the Annual Enrollment PeriodThe future of health care is one where pharmacists play a pivotal role, and the Annual Enrollment Period is the perfect opportunity to prove it.
Latest:
St. John’s Wort Could Show Benefit in Major Depressive DisorderPatients with MDD may also seek complementary or alternative therapies in the form of dietary supplements which might be perceived by patients to be natural and safer than medicinal agents.
Latest:
Is the 340B Hospitals Battle at the Supreme Court Over?Decision on payment reductions looks fleeting as ruling also provides HHS with instructions on cost-cutting goals.
Latest:
Evaluation of a Chemotherapy Advanced Preparation Pilot Program to Improve Throughput in an Oncology Infusion ClinicPharmacy workflow changes in the preparation of chemotherapy products can reduce patient chair time.
Latest:
Immune Checkpoint Inhibitors Change Treatment Landscape for Metastatic Cervical CancerApproval of a novel antibody-drug conjugate ushers in new second-line option.
Latest:
Novel Treatments Could Turn the Tide for Alzheimer DiseaseAnti-amyloid antibody administration decreased plaque volume in clinical trials of patients with early AD, indicating that passive immunotherapies could be a promising treatment for the disease.
Latest:
Advancement in Stem Cell Transplantation: Improving Outcomes for Patients With Blood CancerAdvances, challenges, and promising innovations emerge.
Latest:
5 Quick Tips to Create a Transformative Advanced Pharmacy Practice Experiences RotationWhat many preceptors may not realize is that in addition to learning about practice settings, all graduates of pharmacy schools in the United States must also be able to demonstrate leadership, innovation, and entrepreneurship.
Latest:
Glucophage Will Activate the Same Pathway as Sprint Exercise to Reduce AppetiteThe oral medication activates an “anti-hunger” molecule which may prevent people from overeating.
Latest:
The Pharmacist’s Role: Opioid-related Risks With a Psychiatric DrugPharmacists dispensing Lybalvi should understand that potentially life-threatening consequences can occur if opioids are taken concurrently.
Latest:
Navigating Pediatric Atopic Dermatitis: Insights Into Treatment, Challenges, and Care ConsiderationsAtopic dermatitis significantly impacts quality of life, and requires personalized management through trigger identification, skin barrier maintenance, and a range of topical, oral, and biologic therapies to reduce symptoms and prevent flare-ups.
Latest:
The Role of Erenumab (Aimovig) in Treating Episodic, Chronic MigrainesErenumab (Aimovig) was the first anti-CGRP agent approved by the FDA for migraine prophylaxis.
Latest:
Concluding Remarks: Collaborative Expertise in an Era of Emerging Cancer TherapiesPanelists discuss how there have been many new agents being studied and released at the current time and how the development of these agents is moving at a rapid pace. The adverse effect profiles of newer antibody-drug conjugates create a greater opportunity for pharmacists to be involved in toxicity management.
